| 期刊簡介 | |||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | MOLECULAR THERAPY LetPub Score 8.8
52 ratings
Rate
Reputation 9.6 Influence 8.1 Speed 9.1 | ||||||||||||||||||||||||||||||||
| 期刊簡稱 | MOL THER | ||||||||||||||||||||||||||||||||
| ISSN | 1525-0016 | ||||||||||||||||||||||||||||||||
| E-ISSN | 1525-0024 | ||||||||||||||||||||||||||||||||
| h-index | 158 | ||||||||||||||||||||||||||||||||
| CiteScore |
| ||||||||||||||||||||||||||||||||
| 自引率 (2023-2024) | 1.70%自引率趨勢 | ||||||||||||||||||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||||||||||||||||||
| 官方網站 | https://www.cell.com/molecular-therapy-family/molecular-therapy/home | ||||||||||||||||||||||||||||||||
| 在線稿件提交 | https://www.editorialmanager.com/molecular-therapy/default.aspx | ||||||||||||||||||||||||||||||||
| 開放訪問 | Yes (Hybrid OA journal) | ||||||||||||||||||||||||||||||||
| 出版商 | Cell Press | ||||||||||||||||||||||||||||||||
| 主題領域 | 医学 | ||||||||||||||||||||||||||||||||
| 出版國/地區 | UNITED STATES | ||||||||||||||||||||||||||||||||
| 發行頻率 | 月刊 | ||||||||||||||||||||||||||||||||
| 創刊年 | 2000 | ||||||||||||||||||||||||||||||||
| 每年文章數 | 264每年文章數趨勢 | ||||||||||||||||||||||||||||||||
| 黃金OA百分比 | 27.60% | ||||||||||||||||||||||||||||||||
| Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||||||||||
| 索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1525-0016%5BISSN%5D | ||||||||||||||||||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: Time to first decision: 8 days; 來自作者的數據: Average 1 Month(s) | ||||||||||||||||||||||||||||||||
| 競爭力 * | 來自作者的數據: Difficult | ||||||||||||||||||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||||||||||||||||||
| *所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||||||||||||||||||
|
|
| |
| 首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
| [MOLECULAR THERAPY] 的評論 | 撰寫評論 |
| 作者: hover126 領域: 医学 審稿時間: 8.0 month(s) 結果: 修改後接受 撰寫評論 |
2026-04-22 16:47:16 評論於 The first review took about a month to return the review comments, with three reviewers providing dozens of comments that required a lot of additional experiments, especially for clinical data. Many Western blot and fluorescent images also needed to be supplemented. It took over two months to revise and resubmit. The second review took about a month as well, with two reviewers suggesting acceptance, but one reviewer was very meticulous and believed that additional data was needed to address their concerns. We optimized the additional experiments over two months (including delays due to the Spring Festival holiday) and resubmitted in three weeks, which was accepted. |
| 作者: hover126 領域: 医学 審稿時間: 8.0 month(s) 結果: 修改後接受 撰寫評論 |
2026-04-21 08:06:19 評論於 The requirements are very high, with three reviewers and many issues that need to be addressed. Many additional experiments have been requested, resulting in a total of approximately 200 figures in the manuscript. The data volume required is also very large. |
| 作者: 小豆芽131 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2026-04-14 11:15:41 評論於 Does "dip" after "with editor" mean rejection? Does anyone know? |
| 作者: 吴华格 領域: 生物学 審稿時間: 3.0 month(s) 結果: 待定&不明 撰寫評論 |
2026-01-20 14:00:51 評論於 Are there any friends who have submitted contributions recently? |
| 作者: 巷陌巾 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-06-27 15:03:07 評論於 This magazine is so slow. Submitted on 5.02, with editor on 5.14, sent email for follow-up on 6.23 and it's still under decision in progress on 6.27. |
| 作者: zgc005 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2025-01-25 20:31:27 評論於 I personally feel that this magazine is very excellent, relatively objective, and the questions asked by the two reviewers are very professional, which is more friendly to translational medicine. I hope it will become even better in the future. |
| 作者: 西风海云 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-25 12:55:26 評論於 Review speed: 1.0 | Submission acceptance rate: 25.0 Research focus: Oncolytic virus Experience sharing: Will this journal recommend resubmission after rejection? |
| 作者: 沛白少爷 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-21 13:23:01 評論於 The review process is extremely slow. It took nearly a month from submission to being assigned to an editor. Currently, it has not moved to the "Under Review" stage. Can I send an email to expedite the process? |
| 作者: Lucy Larkin 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-08 16:41:39 評論於 There are indeed many advertorials in this magazine! |
| 作者: 东风谷凌波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-03 18:56:09 評論於 Please translate the following passage into English: None |
| 作者: 铁线德惠 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-25 19:10:37 評論於 Can I ask if your status has changed? Mine dipped directly after submission three days ago |
| 作者: 书生淑英 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-04 10:31:37 評論於 Why do you say that? Can you elaborate? |
| 作者: Toby Nahum 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-25 10:02:30 評論於 A pretty lousy journal |
| 作者: 南风慕夏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-20 22:46:34 評論於 Hello, does this magazine require the upload of original data? |
| 作者: Nina Tyler 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-10 17:37:19 評論於 Please translate the following paragraph into English and Japanese, with titles ":" and ":" |
| 作者: Nina Tyler 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-10 12:41:21 評論於 How soon will we have results after the rework? Thank you |
| 作者: 孤云晓夏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-13 18:44:39 評論於 Extremely slow |
| 作者: 孤云晓夏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-13 13:06:25 評論於 Very slow |
| 作者: Nina Tyler 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-10 20:36:00 評論於 Have you gotten any results yet? It's been under review for 4 months and there's still no news |
| 作者: Nina Tyler 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-08 13:41:19 評論於 Review speed: 6.0 | Submission hit rate: 25.0 Emphasized research direction: clinical drug experience sharing: Is it normal to have no results after four months of external review? Thank you |
| 作者: 南风慕夏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-21 23:04:33 評論於 Have you received it? |
| 作者: 南风慕夏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-21 14:08:28 評論於 Has your status changed? |
| 作者: Nina Tyler 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-14 17:18:37 評論於 Hello, may I ask if a paper can be rejected after being under review for 3 months? |
| 作者: 南风慕夏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-04 10:56:20 評論於 Hello, do you have the status of the wi th editor? |
| 作者: 仙灵涵涵 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-19 13:56:24 評論於 No, it is after under review |
| 首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
Contact us